Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

Item
http://www.wikidata.org/entity/Q26824723
Mycophenolate revisited.Generic immunosuppression in transplantation: current evidence and controversial issues.Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?Advances in pharmacotherapy to treat kidney transplant rejection.Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients.Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation.De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.On assessing bioequivalence and interchangeability between generics based on indirect comparisons.Limustin®, a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients.
P2860

Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

Item
http://www.wikidata.org/entity/Q26824723
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@ast
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@en
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@nl
type
label
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@ast
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@en
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@nl
prefLabel
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@ast
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@en
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Methods, strengths, weaknesses ...... ard to immunosuppressive drugs
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698